... for predicting overall survival (OS) in patients with ILC and to identify risk factors that affect their survival prognosis. Methods: The patients diagnosed with ILC between 2010 and 2015 were extracted from Surveillance, Epidemiology, and End Results (SEER) database. They were randomly split into a training set...

...-inflammation value PILE Prognosis Breast cancer is a heterogeneous cancer that can be subdivided into subgroups based on histopathology, molecular characteristics, and gene expression patterns and may have different responses and clinical outcomes to different treatment modalities [ 1 ]. According...

... aimed to explore the effects of lipid levels on tumor-infiltrating lymphocytes (TILs) and prognosis in patients with triple-negative breast cancer (TNBC). Methods: Samples from 222 patients with TNBC from July 2007 to December 2019 were obtained from the tissue specimen banks in 3 hospitals. The blood...

... (FAR) and lymphocyte-to-monocyte ratio (LMR), may predict survival of patients with various solid tumors [ 4‒7 ]. The available data in a meta-analysis implied that LMR indicated better prognosis and better efficacy of neoadjuvant chemotherapy. Besides, increased FAR significantly correlated...

... ]. Early breast cancer Prognosis Chemotherapy Gene expression signatures Endocrine response Marcus Schmidt reports personal fees from AstraZeneca, BioNTech, Daiichi Sankyo, Eisai, Lilly, MSD, Novartis, Pantarhei Bioscience, Pfizer, Pierre Fabre, Roche, and SeaGen. His institution has received...

...Akiko Tobe; Yoshiya Horimoto; Kazuki Kobayashi; Nozomi Kamisada; Minoru Hirano Background: Diabetes and the etiology of breast cancer are clearly associated. However, the impact of diabetes on prognosis is not yet understood. Therefore, we conducted a retrospective cohort study to examine...

...-negative breast cancer subtypes Luminal androgen receptor Prognosis Triple-negative breast cancer (TNBC) comprises 10–15% of newly diagnosed invasive breast cancers (BCs). TNBC is characterized by lack of expression of estrogen receptor (ER), lack of progesterone receptor (PR), and lack...

...Xue Dong; Congfang Liu; Jiaqi Yuan; Shouman Wang; Nianhua Ding; Yong Li; Yuhui Wu; Zhi Xiao Introduction: The neutrophil-to-lymphocyte ratio (NLR) and stromal tumor-infiltrating lymphocytes (sTILs) are associated with immunogenicity and prognosis of patients with triple-negative breast cancer (TNBC...

..., a pathological complete response (pCR) has been described as generally resulting in a favorable prognosis. However, there are subgroups, such as patients with a mutation in BRCA1 or BRCA2 ,in which the effect of pCR on the prognosis is suspected to be weaker. Patients with a family history of breast...

... effectors of the Hippo pathway facilitate their activity through TEAD transcription factors. Several molecular pathways with known oncogenic functions cross-talk with the Hippo pathway. Methods: A systematic review studying the correlation of the Hippo pathway with BC tumorigenesis, prognosis, and treatment...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. SOX2 HER2 EGFR Prognosis Breast cancer Breast cancer is the most common female...

... prognosticator of a poor prognosis in breast cancer. [email protected] 9 05 2019 4 09 2019 8 10 2019 © 2019 The Author(s) Published by S. Karger AG, Basel 2019 Open Access License / Drug Dosage / Disclaimer This article is licensed under the Creative Commons Attribution...

... in Figure 1 . Table 1. Characteristics of included studies Fig. 1. Flow diagram of search strategy and included studies. Fig. 1. Flow diagram of search strategy and included studies. Breast cancer Breast conservation therapy Multifocal/multicentric breast cancer Prognosis...

... expression Ribosomal protein S6-pS240 Breast cancer Non-special type Immunohistochemistry Marker Prognosis Breast cancer of no special type (NST) is one of the most common malignancies worldwide. Personal history, environmental factors, as well as hormonal and reproductive status...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Focal adhesion kinase Breast cancer Node-negative Prognosis Protein...

... whether the prognosis for HER2-positive patients treated with adjuvant trastuzumab differs from that of HER2-negative patients. Methods: We performed a retrospective study including patients with lymph node-negative invasive breast cancer treated at our institution in the period 2000-2009. Disease-free...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. MammaPrint 70-Gene expression profile Breast cancer Japanese patients Prognosis The decision to perform adjuvant chemotherapy in breast cancer patients has...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prognosis Male breast cancer Metastasis Male breast cancer (MBC) is a rare disease accounting for approximately 1% of all malignancies in men [ 1,2 ] and being...

... cancer Prognosis Chemotherapy It is evident that the magnitude of chemotherapy benefit depends on the level of risk of the individual patient [ 1 ]. In order to avoid both over- and undertreatment, it is advisable to select the appropriate treatment strategy on the basis of a careful risk...

... exists in the literature regarding the role of pregnancy in the prognosis of breast cancer. We designed a matched case-case study, matching pregnancy-associated breast cancer (PABC) cases with breast cancer cases for stage, age, and year of diagnosis. Patients and Methods: 39 consecutive cases of PABC...